PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30930248-7 2019 PTGS-2 inhibitors CAY10404 and NS398 effectively decreased the secretion of PGE2 and the expression of prostaglandin synthetases, pro-inflammatory factors and DAMPs, and alleviated LPS-induced tissue damage. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 31-36 prostaglandin-endoperoxide synthase 2 Bos taurus 0-6 9374663-5 1997 NS-398 (500 nM), a specific PGHS-2 inhibitor, was ineffective. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 0-6 prostaglandin-endoperoxide synthase 2 Bos taurus 28-34 24447957-8 2014 Treatment with PTGS2 selective inhibitor (NS398), PTGS2-specific siRNA or PTGER2-receptor antagonist (AH6809) resulted in ~20-25% reduction in nuclear maturation. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 42-47 prostaglandin-endoperoxide synthase 2 Bos taurus 15-20 24377862-8 2014 During IVM, PTGS2 activity inhibitor NS398 (50 muM) led to lower expression of fatty acid synthase (FASN) in CC and of MOS in treated metaphase-II oocytes. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 37-42 prostaglandin-endoperoxide synthase 2 Bos taurus 12-17 21293029-3 2011 The specific inhibition of PTGS2 activity with NS-398 during in vitro maturation (IVM) significantly restricted mitogen-activated protein kinase (MAPK) activation in oocytes at the germinal vesicle breakdown stage and reduced both cumulus expansion and the maturation rate after 22 h of culture. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 47-53 prostaglandin-endoperoxide synthase 2 Bos taurus 27-32 15216991-1 2004 Ultrasound-mediated intrafollicular injection and aspiration procedures were used to investigate the ability of the selective cyclooxygenase-2 inhibitor, NS-398, to inhibit intrafollicular PGE2 synthesis and suppress ovulation in dairy cattle. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 154-160 prostaglandin-endoperoxide synthase 2 Bos taurus 126-142 15216991-0 2004 Inhibition of intrafollicular PGE2 synthesis and ovulation following ultrasound-mediated intrafollicular injection of the selective cyclooxygenase-2 inhibitor NS-398 in cattle. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 159-165 prostaglandin-endoperoxide synthase 2 Bos taurus 132-148 18463360-10 2008 A specific inhibitor of cyclooxygenase (PTGS), PTGS2 (NS-398), also reduced cell viability, whereas an inhibitor of PTGS1 (FR122047) did not affect it. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 54-60 prostaglandin-endoperoxide synthase 2 Bos taurus 47-52 16855213-6 2006 The prostaglandin-endoperoxide synthase 2 (PTGS2) inhibitor NS-398 caused a region-dependent decrease in SCs and tone. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 60-66 prostaglandin-endoperoxide synthase 2 Bos taurus 4-41 16855213-6 2006 The prostaglandin-endoperoxide synthase 2 (PTGS2) inhibitor NS-398 caused a region-dependent decrease in SCs and tone. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 60-66 prostaglandin-endoperoxide synthase 2 Bos taurus 43-48 12672504-10 2003 Furthermore, PgE-2 release following exposure of BBMEC monolayers to either LPS or the various amphotericin-B formulations was reduced by the addition of the selective COX-2 inhibitor, NS-398. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 185-191 prostaglandin-endoperoxide synthase 2 Bos taurus 168-173 12419090-5 2002 In bovine iridial melanocytes, latanoprost acid caused a significant increase of the PGE(2) production, which could be blocked by indomethacin and NS398, indicating an involvement of cyclo-oxygenase 2. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 147-152 prostaglandin-endoperoxide synthase 2 Bos taurus 183-200